FIELD: medicine.
SUBSTANCE: ophthalmic composition contains a water carrier ingredient and an effective amount of at least one compatible soluble substance for eye surface protection against hyperosmotic stress where the compatible soluble substance is chosen from a group consisting of carnitine and erythrite. The ophthalmic composition has osmolarity in the range 200 to 1000 mOsmol/kg. Also, the ophthalmic composition can contains glycerine and carboxymethyl cellulose, a preserving agent. The ophthalmic composition delivers compatible soluble substances to eye surface cells to counterbalance an osmotic stress thereon. The composition is applied for manufacturing a drug for eye surface protection against hyperosmotic stress. A method of treating human dry eye keratitis involves administration of said composition.
EFFECT: eye protection in adverse effect of cationic compounds on the eye surface and simplified process of eye restoration following a surgical intervention.
13 cl, 7 tbl, 8 dwg, 20 ex
Title | Year | Author | Number |
---|---|---|---|
ARTIFICIAL TEARS AND THERAPEUTIC APPLICATION | 2010 |
|
RU2589837C2 |
ARTIFICIAL TEARS COMPRISING SODIUM HYALURONATE AND CARBOXYMETHYLCELLULOSE | 2014 |
|
RU2687275C2 |
COMPOSITION CONTAINING THERAPEUTICALLY ACTIVE INGREDIENTS HAVING INCREASED SOLUBILITY | 2001 |
|
RU2291685C2 |
ASCOMYCIN-CONTAINING OPHTHALMIC COMPOSITION | 2002 |
|
RU2313344C2 |
METHODS AND COMPOSITIONS FOR TREATING DRY EYE | 2008 |
|
RU2470662C2 |
DRY EYE TREATMENT COMPOSITIONS | 2012 |
|
RU2651046C2 |
STABILIZED OPHTHALMIC COMPOSITIONS CONTAINING OMEGA-3-ACIDS | 2015 |
|
RU2697844C2 |
OPHTHALMIC COMPOSITIONS CONTAINING COOPERATIVE COMPLEXES OF LOW- AND HIGH-MOLECULAR HYALURONIC ACID | 2016 |
|
RU2733733C2 |
OPHTHALMOLOGICAL COMPOSITION, BASED ON POLYUNSATURATED FATTY ACIDS OMEGA-3 AND OMEGA-6 | 2010 |
|
RU2545675C2 |
OPHTHALMIC COMPOSITIONS OF TAMARIND SEED POLYSACCHARIDE AND HYALURONIC ACID | 2008 |
|
RU2493855C2 |
Authors
Dates
2011-01-27—Published
2005-11-14—Filed